New treatments and drugs are tested extensively before they come on the market using randomised controlled trials (RCTs). We talk to David Spiegelhalter (Winton Professor of the Public Understanding of Risk), Sheila Bird (Professor at the Medical Research Council Biostatistics Unit), and Nigel Hawkes (journalist and director of Straight Statistics) about why RCTs are used and how they test if a new treatment works. You can also read an accompanying article.

Listen to the podcast.

Labels: Evidence based medicine, Health and medicine, podcast